Drugs / Menadione
Menadione
also known as
1,4-naphthalenedione, 2-methyl · Kayquinone · Menadione Topical Lotion · MTL · NSC-4170 · Vitamin k 3
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00656786 | Apr 2008 → Dec 2009 | — | Spectrum Pharmaceuticals, Inc | Completed | No outcome recorded |
| Phase not applicable1 trial · 1 missed | ||||||
| — | NCT01393821 | Jan 2012 → May 2013 | cancer, toxic dermatosis | Mayo Clinic | Completed | Missed primary |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Menadione | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00656786 ↗ |
| Known as | 1,4-naphthalenedione, 2-methyl | ChEMBL registry synonym — accepted as the source's own label CHEMBL590 ↗ |
| Known as | Kayquinone | ChEMBL registry synonym — accepted as the source's own label CHEMBL590 ↗ |
| Known as | Menadione Topical Lotion | “This is a clinical research study of an experimental new medication, Menadione Topical Lotion (MTL).” NCT00656786 ↗ |
| Known as | MTL | “This is a clinical research study of an experimental new medication, Menadione Topical Lotion (MTL).” NCT00656786 ↗ |
| Known as | NSC-4170 | ChEMBL registry synonym — accepted as the source's own label CHEMBL590 ↗ |
| Known as | Vitamin k 3 | ChEMBL registry synonym — accepted as the source's own label CHEMBL590 ↗ |
| Modality | Small molecule | — CHEMBL590 ↗ |
| Route | Topical | “Menadione Lotion will be applied topically twice a day” NCT00656786 ↗ |